
About Legacy Pharma
Legacy Pharma is a Healthcare company based in George Town, Grand Cayman. Legacy Pharma is engaged in distributing prescription pharmaceutical products. It operates on a Reseller / Distribution model. Legacy Pharma has completed 1 acquisition, including InterMune. Legacy Pharma offers products and services including Betapace and Zanaflex. Its focus areas include Pharmaceuticals and Prescription Drugs.
Company details
Legacy Pharma Inc. SEZC is involved in the distribution of established prescription pharmaceutical products. The company focuses on ensuring that in-demand brands remain accessible to patients who require them. Operations are conducted in the healthcare sector, specifically targeting the availability of critical medications for various conditions. Solutions are provided through a portfolio of products addressing arrhythmias, spasticity, and other medical needs.
- Headquarters George Town, Grand Cayman
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website legacypharmainc.com
- Investments & Acquisitions
Products & Services of Legacy Pharma
Legacy Pharma offers a comprehensive portfolio of products and services, including Betapace and Zanaflex.
Betapace is used to treat life-threatening ventricular arrhythmias.
Zanaflex is used to manage spasticity in patients.
People of Legacy Pharma
2 people are tracked at Legacy Pharma (2 in leadership).
| Name | Role | Group |
|---|---|---|
Adeel Ahmad | Chief Financial Officer | Leadership |
Mark Thompson | CEO | Leadership |
Complete people profiles for Legacy Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Legacy Pharma
Legacy Pharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include InterMune.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Therapies in pulmonology and orphan fibrotic diseases. | intermune.com | Brisbane, United States | 1998 | Feb 2025 | β’β’β’β’ |
Complete acquisition details for Legacy Pharma
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Legacy Pharma
Legacy Pharma Inc. SEZC is involved in the distribution of established prescription pharmaceutical products. The company focuses on ensuring that in-demand brands remain accessible to patients who require them. Operations are conducted in the healthcare sector, specifically targeting the availability of critical medications for various conditions. Solutions are provided through a portfolio of products addressing arrhythmias, spasticity, and other medical needs.
Legacy Pharma offers Betapace and Zanaflex.
Legacy Pharma has made 1 acquisition, including InterMune.